Kennedy Jr. touted CGMs at a Congressional hearing, coinciding with FDA clearances for Dexcom and Abbott devices.

1 report, 0 independent Updated Jul 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Robert F. Kennedy Jr.Dexcom FDA

Keep exploring

Part of

Robert F. Kennedy Jr. discussed the MAHA push with Congress, involving companies like Dexcom and Abbott Laboratories. All 1 developments

The entities involved

Robert F. Kennedy Jr.
American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)
- Robert F. Kennedy Jr. visited Clinton Township to announce funding as part of Donald Trump's Great American Recovery Initiative.Mon 08:37
- An outbreak in Lancaster County, Pennsylvania, has drawn comments from officials regarding vaccine policy, involving figures like Robert F. Kennedy Jr. and those connected to Donald Trump.Mon 06:20
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jul 1Unknown outlet